FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1149152001: Trilaciclib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4554214018 Trilaciclib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4554215017 Trilaciclib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4554214018 Trilaciclib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4554215017 Trilaciclib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trilaciclib Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Trilaciclib Is a Protein kinase inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Trilaciclib Is a Enzyme inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Trilaciclib Has disposition Protein kinase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Trilaciclib Is a Pyrrole true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Trilaciclib dihydrochloride Is modification of (attribute) True Trilaciclib Inferred relationship Existential restriction modifier (core metadata concept)
Trilaciclib only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trilaciclib Inferred relationship Existential restriction modifier (core metadata concept) 1
Trilaciclib-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trilaciclib Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) False Trilaciclib Inferred relationship Existential restriction modifier (core metadata concept) 1
Trilaciclib-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trilaciclib Inferred relationship Existential restriction modifier (core metadata concept) 1
Trilaciclib only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trilaciclib Inferred relationship Existential restriction modifier (core metadata concept) 1
Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial Has basis of strength substance (attribute) True Trilaciclib Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start